Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
Indian J Exp Biol ; 2007 Aug; 45(8): 720-5
Article in English | IMSEAR | ID: sea-62738

ABSTRACT

Cefazolin injection (3000 mg/kg, i.v.) in mice showed several behavioral excitations such as wild running, jumping, rolling, and finally undergoing severe convulsions followed by death. It's lower doses (500-2000 mg/kg, i.v.) were unable to produce any convulsions or behavioral excitations in mice. However, cefazolin (500 or 1000 mg/kg, i.v.) when administered before different doses of pentylenetetrazol (PTZ; 40 or 60 mg/kg, i.p.) or picrotoxin (PTX; 4 or 8 mg/kg, i.p.), it produced severe tonic-clonic convulsions in mice. The convulsions or behavioral excitations produced by 3000 mg/kg, i.v. cefazolin was also reversed by different doses of diazepam (0.5-2 mg/kg, i.p.) further proving the GABAergic modulatory effect of cefazolin. The results conclude the pro-convulsant action of cefazolin on PTZ- or PTX-induced convulsions, and further confirm the clinical reports.


Subject(s)
Animals , Anti-Bacterial Agents , Behavior, Animal/drug effects , Cefazolin/toxicity , Convulsants/toxicity , Male , Mice , Mice, Inbred Strains , Pentylenetetrazole/toxicity , Picrotoxin/toxicity , Receptors, GABA-A/antagonists & inhibitors , Seizures/chemically induced
2.
Indian J Physiol Pharmacol ; 2004 Apr; 48(2): 191-8
Article in English | IMSEAR | ID: sea-106183

ABSTRACT

Nitric oxide (NO) has been demonstrated to enhance memory formation in experimental animals. However, the effect of NO precursor, L-arginine has never been tested on the memory impairing action of the aniepileptic drug, phenobarbitone independently and concurrently with the convulsant, picrotoxin (PCT). In view of this, in the present study, rats that acquired the shock avoidance task were treated with PCT (5 mg/ kg). Twenty four h later these animals were injected with L-arginine (500, 1000 mg/kg) and phenobarbitone (10, 20 mg/kg). Retention of the acquired task was tested 30 min later. The effect of these compounds were correlated with the changes produced by them on the concentration of NO in the brain. PCT and phenobarbitone (20 mg/kg) inhibited memory process independently and concurrently. NO concentration was not altered by phenobarbitone but was decreased in PCT-treated animals. L-arginine (1000 mg/kg) increased the concentration of NO in PCT and phenobarbitone treated animals and prevented these compounds from impairing memory process independently and concurrently. These results lead to a conclusion that L-arginine may be used in combination with phenobarbitone to prevent both the cognitive side effect of the antiepileptic drug and the impairment of memory that is associated with the convulsion disorder.


Subject(s)
Animals , Arginine/pharmacology , Male , Memory Disorders/chemically induced , Nitric Oxide/metabolism , Phenobarbital/pharmacology , Picrotoxin/toxicity , Rats , Rats, Wistar , Reaction Time/drug effects , Seizures/chemically induced
3.
Indian J Physiol Pharmacol ; 2003 Oct; 47(4): 400-6
Article in English | IMSEAR | ID: sea-107736

ABSTRACT

There are no reports on the effect of 7-nitroindazole (7-NI) on chemically-induced convulsions. Hence, in the present study, its (100 and 200 mg/kg) action was tested alone and in combination with phenobarbitone (20 mg/kg) and diazepam (0.25 mg/kg) on picrotoxin (PCT)-induced convulsions in rats. The changes produced by 7-NI on nitric oxide synthase (NOS) activity and nitric oxide (NO) concentration were determined in the brain. The effect of 7-NI was tested in L-arginine (1000 mg/kg) pretreated (30 min) animals. The smaller dose (100 mg/kg) of 7-NI did not alter NOS activity and NO concentration, but inhibited PCT-induced convulsions indicating that its anticonvulsant action was devoid of an involvement of NO. But, an inhibition of NOS activity, by a larger (200 mg/kg) dose of it, resulted in a promotion of the convulsant action of PCT and in an impairment of the anticonvulsant effect of both phenobarbitone and diazepam. The proconvulsant action of 7-NI was reverted by L-arginine. These results suggest that 100 and 200 mg/kg of 7-NI produce distinguishable action on PCT-induced convulsions because NOS activity is inhibited by 200 mg/kg and not by 100 mg/kg of it. The results further suggest that NO acts as anticonvulsant and that the NOS inhibitors, like 7-NI, cannot be used as an anticonvulsant either alone or in combination with other anticonvulsants.


Subject(s)
Animals , Diazepam/therapeutic use , Dose-Response Relationship, Drug , Drug Therapy, Combination , Indazoles/adverse effects , Male , Phenobarbital/therapeutic use , Picrotoxin/toxicity , Rats , Rats, Wistar , Seizures/chemically induced
4.
Indian J Physiol Pharmacol ; 1999 Oct; 43(4): 479-85
Article in English | IMSEAR | ID: sea-108397

ABSTRACT

The effect of L-arginine (840 mg/kg) pre- (30 min before challenge) and post-treatment (5 min after challenge) period was tested on picrotoxin-induced increase in ammonia concentrations in brain regions (cerebral cortex, brain stem and cerebellum) and the accompanying convulsive responses in adult male rats. The combined effect of L-arginine and diazepam was also tested against picrotoxin-induced convulsions. Picrotoxin-induced increase in ammonia was reverted partially by L-arginine pretreatment. However, L-arginine pretreatment did not show anticonvulsant effect independently or concurrently with diazepam. On the other hand, L-arginine post-treatment reverted ammonia to control level in all brain regions. A partial but significant inhibition of convulsion responses was found in these animals. The combined effect of diazepam and L-arginine post-treatment was much greater than that produced by these agents independently. These findings suggest that ammonia has a partial but significant participation in the convulsant action of picrotoxin. L-arginine has a potential to revert brain ammonia to control level in picrotoxin-treated animals and thereby it has produced a partial protection. The data further indicate that the duration of action of L-arginine is considerably short and has an additive anticonvulsant action with diazepam.


Subject(s)
Ammonia/metabolism , Animals , Anticonvulsants/administration & dosage , Arginine/administration & dosage , Brain/drug effects , Brain Stem/metabolism , Cerebellum/metabolism , Cerebral Cortex/metabolism , Diazepam/administration & dosage , Male , Picrotoxin/toxicity , Rats , Rats, Wistar , Seizures/chemically induced , Tissue Distribution , gamma-Aminobutyric Acid/metabolism
5.
Zagazig Medical Association Journal. 1992; 5 (3): 275-282
in English | IMEMR | ID: emr-26750

ABSTRACT

The present study was designed to study the effect of pre-treatment with the cyclooxygenase inhibitors non-steroidal anti-inflammatory drugs [NSAIDS]; indomethacin, ketoprofen and tiaprofenic acid on the picrotoxin-induced seizures in albino mice. Picrotoxin was injected i.p in two doses of 8 and 16 mg/kg one hour after i.p injection of indomethacin [25 mg/kg], ketoprofen [100 mg/kg] or tiaprofenic acid [200 mg/kg]. Convulsions were assessed by the following parameters: the protection from convulsions, the time to onset of colonic or tonic seizures, the duration of convulsion [terminated by death] and the incidence of death occurring in one hour. The results of the present work demonstrated that non of the fore mentioned parameters for assessment of seizures induced by 8 or 16 mg/kg picrotoxin were significantly changed by prior administration of indomethacin, ketoprofen and tiaprofenic acid indicating that prostaglandins are not involved in such process


Subject(s)
Picrotoxin/toxicity , Seizures/chemically induced , Mice
6.
Article in English | IMSEAR | ID: sea-17466

ABSTRACT

The effect of propranolol was assessed against myoclonus induced by picrotoxin (a known GABA antagonist) in a dose of 3 mg/kg and allylglycine (the inhibitor of GABA synthesis and release) in a dose of 150 mg/kg. A dose-dependent (0.5-2 mg/kg) protective effect was found against both models. Pretreatment of rats with a GABA-reducing dose (100 mg/kg, nonmyoclonic) of allylglycine produced no change in the effect of propranolol against picrotoxin-induced myoclonus. Propranolol thus inhibited myoclonic responses when both the receptor activity and the functional pool of GABA were impaired, suggesting that it produces as antimyoclonic action without the involvement of GABA. However, the drug seems to show a synergistic action with GABA-ergic agents, as greater protection was observed in rats treated concurrently with propranolol and amino-oxyacetic acid, an inhibitor of GABA degradation.


Subject(s)
Acetates/therapeutic use , Aminooxyacetic Acid/therapeutic use , Animals , Drug Synergism , Male , Myoclonus/chemically induced , Picrotoxin/toxicity , Propranolol/therapeutic use , Rats , Rats, Inbred Strains
7.
Indian J Physiol Pharmacol ; 1988 Jul-Sep; 32(3): 221-2
Article in English | IMSEAR | ID: sea-106307
SELECTION OF CITATIONS
SEARCH DETAIL